ANCA相关性血管炎心血管疾病的机制、临床表现与管理
本综述整合ANCA相关性血管炎(AAV)中心血管疾病的发病机制、临床表现和管理证据,指出AAV患者心肌梗死、缺血性卒中和静脉血栓栓塞风险高于一般人群,炎症活动是早期心血管事件的关键驱动因素,需多学科管理以减少心血管损害累积和死亡。
要点
- AAV患者心肌梗死、缺血性卒中和静脉血栓栓塞风险高于一般人群。
- 炎症活动是AAV早期心血管事件的关键驱动因素。
- AAV心血管风险呈时间依赖性轨迹,需多学科管理。
核心结论
- AAV患者面临显著的心血管和血栓风险,炎症活动是早期心血管事件的关键驱动因素。
- AAV心血管风险随疾病进程呈时间依赖性演变,需多学科管理以限制心血管损害累积和相关死亡。
研究设计与样本
- 综述整合AAV中心血管疾病的发病机制、临床表现和管理证据。
主要发现
- AAV患者心肌梗死、缺血性卒中和静脉血栓栓塞发生率高于一般人群。
- 心血管风险 excess 反映疾病相关炎症、传统心血管危险因素和治疗毒性之间复杂的、时间依赖性的相互作用。
- 炎症活动是早期心血管事件的关键驱动因素。
临床怎么用
- AAV管理需多学科协作,以限制心血管损害累积和相关死亡。
- 应关注AAV病程中时间依赖性的心血管风险演变。
局限性
- 本文为综述,未报告原始研究的具体样本量、效应值或置信区间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ANCA-associated vasculitides (AAVs) are rare diseases characterized by small-vessel necrotizing vasculitis, multiorgan involvement and positivity for ANCAs. The main phenotypes are granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis, representing distinct yet partially overlapping entities in terms of pathogenesis, clinical expression and therapeutic management. Patients with AAV face a substantial cardiovascular (CV) and thrombotic risk, with higher rates of myocardial infarction, ischaemic stroke and venous thromboembolism than the general population. The excess CV burden reflects a complex, time-dependent interplay between disease-related inflammation, traditional CV risk factors and treatment-related toxicity, with inflammatory activity emerging as a key driver of early CV events. Across the disease course, this evolving risk profile requires multidisciplinary management to limit CV damage accrual and related mortality. This review integrates evidence on pathogenesis, clinical manifestations and management of CV disease in AAV, highlighting its time-dependent trajectory and key unmet needs.
引用
- Chiara E, Bagni G, Raho A, et al. Mechanisms, clinical manifestations and management of cardiovascular diseases in ANCA-associated vasculitis. Rheumatology (Oxford). 2026. PMID: 42391608. doi:10.1093/rheumatology/keag268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。